Indian pharmaceutical stocks soared after the US exempted drugs from reciprocal tariffs. Gland Pharma and Aurobindo Pharma ...

Mumbai: Benchmark indices Sensex and Nifty closed down on Thursday due to selling in IT shares amid a global sell-off as US ...

As per Geojit Investments report, Zydus Lifesciences' 47 percentage of revenue comes from the US. Similarly, Aurobindo Pharma ...

Indian stock market settled in the red but outperformed Asian peers after the US President Donald Trump announced sweeping ...

Indian benchmark indices, Sensex and Nifty, opened lower on Friday, pressured by IT stocks, as weak global cues and U.S.

As trade tensions between India and the US escalate with President Trump’s latest tariff announcement, longstanding concerns ...

Donald Trump's reciprocal tariff announcement to mark ‘liberation day’ for the US increased fears of a global recession due ...

Nifty and Sensex surged on April 2, recovering from a two-day decline, influenced by banking and IT stocks. The Sensex rose ...

IT shares were the top Sensex and sectoral losers over fears of recession as experts see additional tariffs detrimental to ...

Shares of Pharmaceutical companies on Thursday jumped more than 14 per cent after the US administration exempted pharmaceuticals from reciprocal tariffs.      In the morning trade, the scrip of Gland ...

Indian indices suffered a drop as the U.S. imposed 26% reciprocal tariffs, though pharma stocks' surge and lower tariffs ...

Indian equity markets slipped during Thursday's trade after Trump announced 26% tariffs on foreign imports to the US.